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Background
Flupirtine is a centrally acting, non-opioid analgesic with
muscle relaxant and neuroprotective properties. Although
routinely used in the clinic, its mechanism of action
remained poorly understood; it had been suggested to
antagonize NMDA receptors and to activate G protein-
coupled inward rectifier (GIRK) and KCNQ K+ channels.
Since spinal GABAA receptors are involved in pain sensa-
tion, we investigated the effects of flupirtine on this and
other transmitter-gated ion channels.
Materials and methods
Perforated patch clamp recordings were obtained in pri-
mary cultures of rat hippocampal, sympathetic and dorsal
root ganglion (DRG) neurons.
Results
Flupirtine (30 μM) enhanced currents evoked by GABA
(10 μM) in all neurons investigated, but this effect was sig-
nificantly larger in DRG than hippocampal or sympa-
thetic neurons. In DRG neurons, flupirtine behaved as
uncompetitive antagonist: it lowered EC50  values for
GABA-induced currents 5.3-fold and depressed maximal
amplitudes by 34%. In hippocampal neurons, EC50 values
were reduced 3.1-fold; maxima remained unchanged. Flu-
pirtine concentration-dependently enhanced currents
evoked by 3 μM GABA up to 8-fold in DRG (EC50: 21 μM)
and 2-fold in hippocampal neurons (EC50: 13 μM). In
hippocampal, but not DRG, neurons, flupirtine (100 μM)
alone elicited inward currents that were not additive to
those evoked by pentobarbital, abolished by bicuculline,
but not altered by flumazenil. Flupirtine (10 μM) failed to
affect currents through NMDA, AMPA/kainate, glycine or
nicotinic receptors in hippocampal and sympathetic neu-
rons, respectively; it also failed to affect currents through
GIRK1/2 channels, but concentration-dependently acti-
vated currents through KCNQ channels; this effect was
more pronounced in sympathetic than DRG or hippoc-
ampal neurons.
Conclusion
These results reveal flupirtine as subtype-selecting allos-
teric modulator of GABAA receptors; its analgetic action
may thus results from a combined action on GABAA recep-
tors and KCNQ channels in pain pathways.
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